Floatz logo

Metformin

Disorder of Glucose Regulation

SINA Health Education and Welfare TrustSmall moleculePhase 4 / ApprovedActive
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
63/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Disorder of Glucose Regulation cohort.

Asset / SponsorPhaseRating
Exenatide
RenJi Hospital
Phase 4BB
Empagliflozin
SINA Health Education and Welfare Trust
Phase 4BB
Glargine
Federico II University
Phase 4BB
ZIDOVUDINE
Kirby Institute
Phase 4BB
PRAVASTATIN
Kirby Institute
Phase 4BB

View all 28 →

Same molecule, other indications

Metformin is also rated in:

Metabolism and Nutrition DisorderDormant
A
Indicative ·
82 / 100
View asset →
prediabetes syndromeDormant
A
Indicative ·
81 / 100
View asset →
gestational diabetesDormant
A
Indicative ·
81 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →